Comparison tool

Compare peptides

Pick up to three compounds. Useful for deciding whether two peptides in a stack actually do different things, or whether you're paying twice for the same pathway.

Select up to three (1/3)

Comparison results

Attribute
CategorySexual health
Evidence gradeStrong
Also known asBremelanotide, Vyleesi
MechanismSelectively activates MC4R in the hypothalamus, increasing dopaminergic signalling in the medial preoptic area — driving desire itself rather than blood flow, unlike PDE5 inhibitors.
Key benefitsIncreased sexual desire in both sexes · Works independently of vascular function · Effective as an on-demand dose
Side effectsNausea and vomiting · Flushing · Headache · Transient blood-pressure increase
Half-lifeAbout 2.7 hours
AdministrationSubcutaneous auto-injector, 45 minutes before activity
Dosing overview1.75 mg as needed, maximum one dose per 24 hours
StorageRoom temperature for the approved auto-injector
Legal statusFDA-approved (Vyleesi) for premenopausal HSDD; other uses are off-label.

Dosing figures reflect published literature and commonly reported community protocols. They are informational only.

Head-to-head comparisons

Each comparison below is its own page with the full attribute table, key differences and shared attributes for that pairing. They are grouped by the category the compounds are indexed under.

GLP-1 receptor agonists

Direct comparisons between the incretin-based compounds most often searched against one another.

Recovery and tissue repair

Pairings between compounds indexed for healing, connective tissue and post-injury recovery.

Growth-hormone axis

Secretagogues and releasing peptides that act on growth-hormone signalling, compared with each other and with adjacent compounds.

Longevity and mitochondrial

Compounds indexed under longevity, cellular and mitochondrial function.

Cognitive and nootropic

Peptides indexed for cognition and mood-related use.

Sexual health

Melanocortin and related compounds indexed for sexual-health use.